Specializing in non-invasive prenatal genetic testing and paternity testing, Ravgen is focused on developing non-invasive prenatal diagnostic tests based on fetal DNA present in maternal blood. Diagnose single gene disorders, such as cystic fibrosis, sickle cell anemia and Downs syndrome, establish paternity and more early on in pregnancy.
| Website | http://www.ravgen.com |
| Revenue | $1 million |
| Employees | 6 (4 on RocketReach) |
| Founded | 2000 |
| Address | 9241 Rumsey Rd, Columbia, Maryland 21045, US |
| Phone | +1 410-715-2111 |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Biotechnology Research, Medical Testing & Clinical Laboratories, Healthcare |
| Keywords | Non Invasive Prenatal Testing, Prenatal Testing, Prenatal Diagnosis, Genetic Testing, Dna Diagnostics, Genetic Screening, Paternity Testing, Molecular Diagnostics, Clinical Diagnostics, Carrier Screening, Newborn Screening |
| Competitors | Quest Diagnostics, Labcorp, Natera, Myriad Genetics, Invitae, Fulgent Genetics, 23andMe, Genomic Health, Color, Strata Oncology +31 more (view full list) |
| SIC | SIC Code 807 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 621 Companies, NAICS Code 62 Companies, NAICS Code 62151 Companies, NAICS Code 6215 Companies |
Looking for a particular Ravgen employee's phone or email?
The Ravgen annual revenue was $1 million in 2026.
Rav Dhallan is the Chairman and Chief Executive Officer of Ravgen.
4 people are employed at Ravgen.
Ravgen is based in Columbia, Maryland.
The NAICS codes for Ravgen are [621, 62, 62151, 6215].
The SIC codes for Ravgen are [807, 80].